Skip to content

Handgrip Strength (HGS) With HGS Asymmetry Are Associated With All-cause Mortality and Hospital Readmissions

Handgrip Strength (HGS) With HGS Asymmetry is Associated With All-cause Mortality and Hospital Readmissions Among Elderly Patients With Gastric Cancer.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05397444
Enrollment
342
Registered
2022-05-31
Start date
2021-03-01
Completion date
2022-03-30
Last updated
2022-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Brief summary

Adding the handgrip strength (HGS) asymmetry to the existing measurements of low HGS may improve the assessment of muscle function.

Detailed description

We sought to explore the associations between maximal HGS with HGS asymmetry and mortality, hospital readmissions, total complications, and prolonged length of stay (PLOS) among elderly patients with gastric cancer.

Interventions

OTHERNo intervention

This is an observational study with no intervention.

Sponsors

Nanjing Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* with gastric cancer * aged ≥60 years * were scheduled to undergo radical surgery for the first time

Exclusion criteria

* received preoperative radiotherapy or chemotherapy * combined with other types of malignant tumors

Design outcomes

Primary

MeasureTime frameDescription
All-cause mortalityabout 3 monthswithin 3 months after surgery, collected from telephone follow-up
Hospital readmissionsabout 3 monthswihthin 3 months after surgery, collected from telephone follow-up

Secondary

MeasureTime frameDescription
Total complicationsabout 3 monthsduring hospitalization, collected from medical records
prolonged length of stayabout 3 monthsduring hospitalization, collected from medical records

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026